China Resists Imports For HIV Drugs As Drug-Resistant Strains Spotted
This article was originally published in PharmAsia News
Parts of China are seeing for the first time drug-resistant strains of HIV that have moved beyond the high-risk population to the general public. The director of the AIDS Institute in Hong Kong called the trend "alarming" because there are few drugs available in China to treat the disease. Chen Zhiwei said the country did not know yet whether the drug-resistant strains are spreading. He said the government had resisted appeals by researchers to import more varieties of HIV drugs. Twenty are available, but China has only seven. (Click here for more
You may also be interested in...
Perrigo, Pfizer want the US FDA to postpone its March 1 deadline for conducting nitrosamine risk assessments. Generics exec cites“serious compliance challenges” in conducting these assessments due to difficulty in finding the right lab equipment necessary to quantify nitrosamine daily intake limits.
Deal snapshot: For $425m up front, the pharma obtains a Phase III recombination fusion protein that shows ability to improve hospitalized patients’ clinical status and reduce risk of death.
Previous businesses FDA warned about COVID-19 claims for chlorine dioxide, a bleach solution, were marketing dietary supplements unlawfully. But Pro Breath MD's oral rinses available under the Dentist Select and OraCare brands are allowed and FDA isn’t asking the firm to discontinue distribution.